Inhibition of axonal outgrowth in the tumor environment: involvement of class 3 semaphorins

Ivan H Vachkov1, Xiaoyong Huang, Yoshihiro Yamada

  • 1Department of Stem Cell Biology, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8640, Japan.

Cancer Science
|May 15, 2007
PubMed

Insights

Tumors may suppress nerve growth by secreting class 3 semaphorins, molecules that guide axons. This study found these molecules inhibit axonal extension from dorsal root ganglion neurons without affecting differentiation.

Area of Science:

  • Neuroscience
  • Cancer Biology
  • Molecular Biology

Background:

  • Tumor innervation is a known phenomenon, yet the underlying molecular mechanisms are poorly understood.
  • Class 3 semaphorins are a family of axon guidance molecules implicated in neural development and tissue patterning.

Purpose of the Study:

  • To investigate the molecular basis for the lack of nerve infiltration in tumors.
  • To determine the effect of tumor-secreted factors on neuronal axonal outgrowth and differentiation.

Main Methods:

  • Cultured embryonic Institute of Cancer Research (ICR) mouse dorsal root ganglion (DRG) cells.
  • Exposed DRG cells to conditioned media from Colon 26 and B16 mouse tumor cell lines.
  • Assessed axonal outgrowth and cellular differentiation.
  • Investigated the role of class 3 semaphorins and their receptor, neuropilin-1, using blocking antibodies.

Main Results:

  • Tumor-conditioned media significantly suppressed axonal extension from DRG neurons.
  • No significant effect on neuronal or glial differentiation was observed.
  • Tumor cells expressed high levels of class 3 semaphorins.
  • Blocking class 3 semaphorin activity with soluble neuropilin-1 partially reversed the inhibition of axonal extension.

Conclusions:

  • Tumor-secreted class 3 semaphorins play a critical role in inhibiting axonal outgrowth of DRG neurons.
  • These findings suggest a novel mechanism by which tumors may evade neural infiltration.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...